Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-12-09Clinical Trial Update: Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma [Phase 2]
Phase 2 trial evaluating anakinra with or without dexamethasone in patients with smoldering or indolent multiple myeloma; results were poste…
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 clinical trial results for a cyclophosphamide, bortezomib, and dexamethasone regimen in newly diagnosed multiple myeloma are reporte…
-
CLINICAL_TRIALS research · 2010-12-01Clinical Trial Update: Technology Platform and System Construction of Clinical Evaluation Studies on New Drugs of Hematological Malignancy
Clinical trial update describing the technology platform and system construction for evaluating new drugs in hematologic malignancies, with …
-
CLINICAL_TRIALS trial_result · 2010-11-30Clinical Trial Update: Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma [Phase 4]
Clinical trial update for a Phase 4 efficacy study comparing PAD and TAD regimens in newly diagnosed multiple myeloma; the status or results…
-
CLINICAL_TRIALS trial_result · 2010-11-25Clinical Trial Update: Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients [Phase 2]
Phase 2 trial of plerixafor (AMD3100) in patients with Non-Hodgkin lymphoma and multiple myeloma has completed with results posted in 2010.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-11-25Clinical Trial Update: AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF [Phase 2]
This Phase 2 trial evaluates using plerixafor (AMD3100) with G-CSF to enhance mobilization of peripheral blood stem cells in patients with m…
-
CLINICAL_TRIALS trial_result · 2010-11-24Clinical Trial Update: Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients [Phase 2]
A Phase 2 trial evaluated stem cell mobilization using AMD3100 (plerixafor) plus G-CSF in patients with non-Hodgkin lymphoma and multiple my…
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil [NA]
This clinical trial update reports termination of a study evaluating tacrolimus with mycophenolate mofetil for graft-versus-host disease pro…
-
CLINICAL_TRIALS withdrawal · 2010-11-10Clinical Trial Update: A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies [Phase 2]
A Phase 2 trial of a novel MUC1-expressing vaccine for tumor malignancies has been withdrawn, including multiple myeloma as an indicated con…
-
CLINICAL_TRIALS trial_result · 2010-11-04Clinical Trial Update: Injection of ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating ex vivo amplified G-CSF-mobilised autologous peripheral blood stem cell transplantation in multiple myeloma has com…
-
CLINICAL_TRIALS trial_result · 2010-11-04Clinical Trial Update: Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma
The trial update reports that combining autologous stem cell transplant with zoledronic acid may improve outcomes in patients with previousl…
-
CLINICAL_TRIALS trial_result · 2010-11-03Clinical Trial Update: Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma [Phase 1]
A completed Phase 1 trial evaluating AVE1642, an anti-IGF1R monoclonal antibody, in patients with advanced multiple myeloma.
-
CLINICAL_TRIALS research · 2010-10-29Clinical Trial Update: Host Dendritic Cells in Allograft Patients [Phase 1]
Phase 1 clinical trial update from Icahn School of Medicine at Mount Sinai evaluating host dendritic cells in allograft patients for relapse…
-
CLINICAL_TRIALS trial_result · 2010-10-22Clinical Trial Update: Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM) [Phase 1, Phase 2]
This trial update reports on the safety and anti-disease activity of CHR-2797 (tosedostat) in elderly and/or treatment-refractory patients w…
-
CLINICAL_TRIALS trial_result · 2010-10-22Clinical Trial Update: Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma [Phase 2]
This document provides an extension study update on the efficacy and safety of oral SCIO-469 in relapsed, refractory multiple myeloma (Phase…
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation [Phase 2]
This is a Phase 2 trial evaluating plerixafor (AMD3100) to mobilize peripheral blood cells in multiple myeloma patients for collection and t…
-
CLINICAL_TRIALS trial_result · 2010-10-18Clinical Trial Update: Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating anti-thymocyte globulin plus melphalan in relapsed multiple myeloma was terminated. Results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-10-18Clinical Trial Update: Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma [Phase 2]
This is a completed Phase 2 clinical trial evaluating oral SCIO-469 in relapsed, refractory multiple myeloma.
-
FDA approval · 2010-10-12FDA Approved: REVLIMID — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for REVLIMID (lenalidomide) submitted by Celgene Corporation.
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis [Phase 2]
Phase 2 clinical trial evaluating high-dose melphalan followed by peripheral stem cell transplantation in patients with amyloidosis. The stu…
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients [Phase 3]
Phase 3 trial evaluating stem cell mobilization with AMD3100 (plerixafor) in multiple myeloma has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 3]
A Phase 3 clinical trial comparing melphalan with or without Holmium-166 DOTMP, followed by peripheral stem cell transplantation, in patient…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating melphalan and busulfan conditioning followed by donor peripheral stem cell transplantation with tacrolimus and me…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating Holmium-166 DOTMP plus Melphalan and peripheral stem cell transplantation in patients with m…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/2 study evaluating donor white blood cell infusions with interleukin-2 in patients undergoin…